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The advent of DNA microarray technology has ushered
in an era of systems biology whereby researchers can
study the transcriptional behavior of thousands of genes
in parallel. Advances in manufacturing techniques and
informatics, and the availability of several genome
sequences have furthered these capabilities to the point
where whole-transcriptome studies can be accom-
plished in yeast, ﬂies and plants, and soon will be pos-
sible in mammals. Concomitant with the expanding
ability of the technology has been the development of
novel techniques and their application towards the
study of cellular biology.
Recent years have seen an exponential rise in the number
of studies that have used DNA chip technology to study
cell biology. Built around the basic principles of nucleic
acid hybridization [1], their most prevalent use so far
has been the detection of steady-state mRNA expression.
These applications include basic molecular annotation
(e.g. Where is my gene? When does it change? Which other
genes change?), discovering disease markers and advanc-
ing the prediction of clinical outcome, as well as a growing
role as the tool of choice for studying transcriptional
output.NewapplicationssuchasgenomicDNAanalysisto
detect DNA synthesis, recombination and chromosomal
duplication and loss, as well as combined chromatin
immunoprecipitationandmicroarraychippingapproaches
to identify transcription factor-binding sites, are being
developed and will enable other areas of biology to be
explored in this same, highly parallel manner. Finally,
alongside sequence query tools, the standardization of
data formats and new display and query tools will further
both the penetrance of these techniques and their
applications in molecular biology.
Because excellent descriptions of the methodologies,
platforms for DNA microarray technologies and publi-
cationformatsareavailableelsewhere(e.g.see[2–4]),this
review focuses on the use of these technologies towards a
better understanding of cell biology (outlined in Fig. 1).
Use of arrays in the study of mRNA expression
DNA arrays have been classically used for investigating
the effect of a given biotic or abiotic perturbation on the
transcriptional output of a system. Underlying these
experiments is the notion that analyzing the response of
a system to a given perturbation can shed light on the
mechanism of signaling or the biological response to the
perturbation, or both. One of the best examples of a
systematicgenome-widestudycomesfromyeast,forwhich
more than 20 different genetic and growth condition
perturbations have been analyzed and used to construct
the galactose utilization regulatory network [5].U s i n gD N A
microarrays and quantitative proteomics, changes in the
expression of mRNA and protein in yeast in response to
each of the conditions were measured. These mRNA and
protein expression data, along with data on protein–protein
interactions,wereusedtoconstructametabolicregulatory
network that conﬁrmed many known regulatory mechan-
isms and uncovered several putative regulatory steps.
A separate systematic study in Arabidopsis has
identiﬁed a transcriptional network underlying a plant’s
response to pathogens [6]. Infection with avirulent
pathogens elicits a broad-spectrum ‘systemic acquired
resistance’ throughout the plant, which requires the accu-
mulation of salicylic acid and is marked by activation of a
setof‘pathogenesis-related’(PR)markergenes.Transcrip-
tional proﬁling of Arabidopsis plants under more than a
dozen conditions of genetic perturbation and microbial
challenge identiﬁed a large cluster of genes that are
coexpressed with PR-1. Promoter analysis of these puta-
tive key mediators of systemic acquired resistance iden-
tiﬁed an over-represented W-box motif TTGAC, which is a
binding site for transcription factors of the WRKY class.
In certain areas of biology, such as development, aging,
the cell cycle and biological rhythms, experiments based
on temporal gene expression proﬁling have advanced our
understanding of these processes. The cell cycle [7–9] and
circadian rhythms [10–13] represent some of the best
examples of successful temporal expression proﬁling, in
part because of the powerful application of curve-ﬁtting
techniques and repeating patterns. In many independent
studies, hundreds of transcripts have been found to show
rhythmic expression patterns in their steady-state mess-
age levels, with a periodicity very close to that of the cell
cycle (e.g. see [7]). These transcripts have been classiﬁed
into separate clusters on the basis of the stage of the
cell cycle corresponding to the peak phase of expression.
In silico analysis of the promoter elements of these gene
clusters has identiﬁed over-represented 50 motifs, many
corresponding to binding sites for known transcription
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motifs, suggesting the involvement of additional tran-
scription factors in regulating the cell cycle.
Acomparisonofgeneexpressionpatternsbetweenwild-
type yeast and a strain containing null mutations in two
members of the highly conserved family of forkhead
transcription factors revealed their roles in regulating
the cell-cycle-dependent expression patterns of genes
importantformitosis [14].Asimilar studyonthe circadian
system in Arabidopsis identiﬁed hundreds of genes show-
ing rhythmic expression patterns in their steady-state
levels of mRNA [12]. Analysis of the promoter regions of
clusters of genes cycling in the evening phase identiﬁed an
over-represented cis-acting 50 motif, which is very similar
to the binding site for transcription factors containing a
Myb domain in mammalian cells. Genetic disruption of
this motif was found to abolish rhythmic expression,
thereby establishing that this cis-acting element has a
crucial role in regulating circadian gene expression.
Collectively, these studies underscore the power of com-
bining large-scale, parallel, experimental approaches such
as DNA arrays with computational and validation tools.
Microarrays in the study of human disease
An increasingly popular application of DNA arrays is in
the study of human disease. The central goals of these
studies have been the early detection of disease pathology,
diagnosis including class and outcome prediction, and the
identiﬁcation of causal disease genes themselves. For
diagnostic markers of human diseases such as cancer,
clinicians have traditionally relied on altered expression
levels of serendipitously discovered genes and proteins.
For example, increased serum levels of prostate-speciﬁc
antigen (PSA) have long been used as an indicator for
prostate cancer, and overexpression of the tyrosine kinase
growth factor receptor, Erb-B2, has been linked to breast
cancer. Typically, however, such markers are limited:
increased serum PSA can also result from benign diseases,
and overexpression of Erb-B2 occurs in only a fraction of
all breast tumors and is not completely predictive of a
individual’s response to Erb-B2 antagonists such as her-
ceptin. Thus, genomic and bioinformatic approaches based
on microarrays can be used to supplement existing tools to
produce more accurate diagnoses.
Proof of principle that these methods can identify
disease-speciﬁc markers comes from the study of two types
of acute leukemia: acute myeloid leukemia (AML) and
acute lymphoblastic leukemia (ALL). Both of these dis-
orders are treatable by traditional chemotherapy; how-
ever, successful treatment is largely dependent on correct
diagnosis. To ﬁnd a distinct molecular signature for these
two diseases, oligonucleotide microarrays were used to
identify a set of 50 genes that can differentiate between
AML and ALL with great accuracy [15]. These methods
have also been extended to the analysis of several classes
of tumor. For example, Su et al. [16] have established a list
Fig. 1. DNA microarrays in systems biology. A typical microarray experiment is designed to measure the spatial and/or temporal expression pattern of genes in a speciﬁc
set of conditions. After data acquisition, analysis is done to identify those genes that change informatively in an experiment. Expression changes can be validated, and the
genes themselves can be mapped to biological pathways or the genome, used for regulatory element analysis or even analyzed across model systems. Several analysis
strategies can be used to identify genes in a given process and/or to model regulatory networks. The adoption of standards in data formatting and annotation, as well
as new databases to disseminate gene expression information, will facilitate analysis within and across different species. Models and/or hypothesis built on microarray
experiments are eventually tested by conventional approaches to ultimately generate new knowledge in systems biology.
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New knowledge in systems biology
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therefore diagnostic of colon, bladder, kidney, liver,
pancreas, ovary,prostate,lung,gastric andbreastcancers.
More recently, it has been possible to show that these
methods can be applied to predicting disease outcome.
Some individuals affected with ALL also have a chromo-
somal translocation in the mixed-lineage leukemia (MLL)
gene. Unfortunately for these people, this additional
translocation is linked to relapse after chemotherapy
and a poor prognosis for survival. Array proﬁling of
leukemic cells taken from individuals with ALL or
ALL/MLL identiﬁed a predictor set of 100 genes with
expression patterns that can differentiate between ALL
and ALL/MLL [17]; in addition, this proﬁling highlighted
themarkedchangesingeneexpressionthatcanoccurwith
chromosomal translocations. It is important to note that
there are many remaining challenges involved in trans-
lating these techniques from the research laboratory to
the clinic. The potential beneﬁts that they facilitate,
however, warrant the considerable attention that these
studies have received.
Applying DNA chip technology to experiments aimed
towardsourunderstandingofdiseasecausalityhasproved
more difﬁcult. Whencoupled with transgenic model organ-
isms, however, microarrays can provide valuable mechan-
istic insight into human disease. Microarray comparisons
between poorly metastatic and highly metastatic melan-
oma lines isolated by in vivo selection in mice detected
a strong correlation between the severity of tumor meta-
stasis and expression of the small GTPase RhoC [18].I n
follow-up experiments, overexpression of RhoC alone in
weakly metastatic melanoma cells enhanced metastasis
in the mouse. Thus, through microarrays, a putative
causal role for RhoC in the development of metastases has
been identiﬁed.
DNA microarrays have also been used to identify con-
tributing factors in the development of the neurological
disease multiple sclerosis, by determining changes in
gene expression in the brains of rats with experimentally
induced autoimmune encephalomyelitis (EAE) – the best-
characterized animal model for multiple sclerosis [19].
This analysis identiﬁed increased expression of the pro-
inﬂammatory cytokine, osteopontin, which has been found
to be also overexpressed in the brain lesions of indi-
viduals affected with multiple sclerosis. Investigation of
osteopontin-deﬁcient mice revealed a requirement for
osteopontin in the normal progression and maintenance
of EAE. From the initial microarray proﬁling of disease
states, genes found to be differentially expressed such
as osteopontin and RhoC could serve as drug targets,
whose inhibition might provide relief for the many people
afﬂicted with devastating diseases such as cancer and
multiple sclerosis.
Gene annotation
One of the most basic uses of arrays in the study of
cell biology is the annotation of gene function by
mRNA expression. After a new gene has been cloned,
basic characterization has traditionally included the
analysisofmRNAexpressionbyamultipletissuenorthern
blot, which is sometimes followed by higher-resolution
techniques such as in situ hybridization. In addition to
providing valuable information conﬁrming the size and
nature of transcripts derived from a structural gene,
implicit in these studies has been the idea that under-
standing where and when a gene is expressed sheds light
on its physiological function.
The recent sequence assembly of mammalian genomes
and subsequent efforts at gene prediction has highlighted
the need for a higher-throughput approach towards
expression annotation. For example, we and others have
looked at the expression of thousands of transcripts from
the mouse across 50 types of tissue, gaining insight into
global patterns of transcription and at the same time
making this information available in publicly available
databases (see [20]).
New methods to predict genes in silico, and the appli-
cation of these methods to several recently solved genome
sequences, have brought about another use for mRNA
expression – that is, transcript validation [21,22]. This
method has several advantages over the use of expressed
sequence tag sequences to quantify gene expression, not
least of which is that it can be directed to any particular
target sequence and thus can be used to validate the
expression of hypothetical, predicted genes.
Transcriptional output and mechanism
An obvious use for DNA arrays is in the study of tran-
scriptional output. By relating transcription factors to the
output genes that they regulate, it is possible to construct
transcriptional regulatory networks that link key factors
to the biology that they control. By characterizing tran-
scription factor deﬁciency and overexpression in cell lines
and mice, several groups have begun to describe such
networks. For example, oligonucleotide microarrays
have been used to compare the transcriptional readouts
of wild-type and transgenic mice with a null mutation in
TAFII105, a gene encoding a cell-type-speciﬁc component
of the RNA polymerase II transcription factor TFIID [23].
The expression of genes from the inhibin–activin–
follistatin folliculogenesis pathway are markedly down-
regulated in the mutant strain, explaining the defects
in ovarian development and fertility found in TAFII105
knockout mice.
This microarray analysis of transgenic organisms has
not been limited to knockout strains. Speciﬁc activation of
the forkhead transcription factor FOXO3a in rat ﬁbro-
blastswasfoundtoinducetheexpressionofgenesinvolved
in cellular responses to stress [24]. One such gene,
Gadd45a, has been characterized further, identifying a
role for FOXO3a in the transcriptional regulation of DNA
repair pathways.
Expanding uses and emerging possibilities
Above we have discussed the use of DNA arrays primarily
in mRNA proﬁling experiments and also several of the
ways in which they are being used to study cell biology.
Recently, however, researchers have been using arrays to
explore other areas of cell biology in the same, highly
parallel, experimentalmanner (summarized in Fig. 2). For
example, the sensitivity and accuracy of microarray
hybridization have been applied to studies of the replication
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DNA copy number at thousands of sites across the genome
during progression through S phase, the sites of origin of
replication were identiﬁed [25]. The temporal distribution
of origin activation, rates of replication fork movement
across the genome, and the relationship between replicating
DNA and transcription during S phase were also explored.
This genomic DNA hybridization technique has also
been used in conjunction with traditional mRNA hybrid-
ization to investigate meiotic transcription in budding
yeast. Primig et al. [26] compared meiotic gene transcrip-
tion in two yeast strains and described considerable
differences in the underlying genomes, including poly-
morphisms and deletions, as well as resultant differences
in mRNA expression patterns. Comparative genomic DNA
hybridization has found an increasingly popular use in
genome-widescansforchangesinDNAcopynumber.Such
studiesonhundredsoftypesoftumorhaveidentiﬁednovel
gene ampliﬁcations (see [27,28] for examples; reviewed in
[29]). Arrays have also been used to interrogate targets of
RNA-binding proteins. For example,in an effortto identify
mRNA-binding targets of fragile X mental retardation
protein (FMRP), Brown et al. [30] immunoprecipitated
FMRP and probed microarrays with the mRNA that
co-immunoprecipitated (Fig. 2). Half of the immunopreci-
pitated mRNAs were found to be translated abnormally
in cells from individuals affected with fragile X and,
notably, many of these mRNA species correspond to genes
implicated in neuronal function and development.
Arrays are also being used to construct transcriptional
networks by monitoring the binding of transcription factors
to yeast genomic DNA directly [31]. This method uses
chromatin immunoprecipitation (ChIP) as a powerful
method to detect physical interactions between known
proteins and their DNA target sites. Instead of sequencing
immunoprecipitatedtargetsgenes,however,Renetal.[31]
used DNA arrays to deconvolute the target identities.
Theydescribe theuse ofthistechnique, ‘ChIP-chip’,forthe
characterization of two transcription factors involved in
carbon utilization and mating, thereby identifying several
known and unknown target genes.
In an independent study, ChIP-chips were used to
also identify unknown origins of replication by immuno-
precipitation of Orc1, the complete ORC complex, as well
as Mcm3, Mcm4 and Mcm7. These proteins are known
to bind DNA and to function in the formation of origins
of replication [32]. In addition, investigations with
ChIP-chips have also led to signiﬁcant understanding of
how transcription factors control speciﬁc processes and
transition stages of the yeast cell cycle. With this method,
it was found that stage-speciﬁc cell-cycle transcription
factors often control the expression of transcription factors
that regulatethenext stage, revealing mechanistic insight
into the continuous transcriptional coordination of the cell
cycle [33]. Furthermore, ChIP-chip analysis has identiﬁed
distinct functional gene clusters (e.g. groups of genes
involved in DNA synthesis orrepair) that are controlled by
speciﬁc cell-cycle transcription factors [34].
The use of ChIP-chips has not been limited to study-
ing DNA-binding transcription factors and can be used
to delineate the functions of histone modiﬁcation
and mRNA-binding proteins. Chromatin remodeling by
Fig. 2. Current applications for DNA microarrays. Classical microarray experiments use isolated genomic DNA or mRNA from a whole organism or tissue. The DNAo r
mRNA is transformed and ampliﬁed into ﬂuorescently labeled cDNA or cRNA, respectively, which is then hybridized to microarrays. These types of experiment have been
used to identify changes in DNA copy number and mRNA expression patterns. Recent innovations in microarray approaches have used an additional puriﬁcation step by
protein immunoprecipitation to identify DNA (chromatin immunoprecipitation or ChIP) or mRNA-binding proteins. Protein bound to DNA or mRNA is ﬁrst crosslinked
and then immunoprecipitated by an antibody to a speciﬁc protein of interest. Crosslinks are then reversed, which releases the co-puriﬁed DNA or mRNA for ampliﬁcation,
labeling and hybridization to microarrays. These procedures have been successful in determining the targets of transcription factors, as well as genomic DNA-binding and
mRNA-binding proteins.
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a chief regulatory mechanism of gene expression. Gene
targets of yeast histone deacetylases (HDACs), which
antagonize chromatin remodeling and gene expression,
have also been identiﬁed by using ChIP-chips [35]. This
study also showed that HDACs display target-site speci-
ﬁcity for their action. Thus, ChIP-chip is emerging as a
powerful tool for the exploration of protein–DNA inter-
actions and its use should provide fertile ground for the
growth of whole-genome transcriptional networks.
Concluding remarks
DNA arrays and the parallel biology that they empower
have pushed experimental approaches to genome-wide
and whole-system levels. Their use in the study of mRNA
expression and transcriptional regulation has been adopted
widely by the research community for exploring virtually
every area of biology. Despite many successes, however,
difﬁcult challenges remain. Importantly, one should have
realistic expectations for the application of DNA arrays,
becausemanyproblemsincellbiologycannotbeaddressed
by looking at transcriptional responses or signatures.
Technical limitations currently prevent higher-
eukaryotic transcriptomes from being analyzed in a
whole-genome fashion. Current sample preparation
methods require relatively large quantities of RNA,
which limits studies on discrete cell types in complex
structures, such as small nuclei in the brain. The cost and
infrastructure required for array experiments remain a
signiﬁcant entry barrier for many laboratories and can
result in studies with less than satisfying experimental
and statistical designs. Current methods to analyze,
visualize and disseminate data are sometimes cumber-
some, expensive or piece-meal, and have not yet been
standardized to facilitate the exchange of data and results
between researchers.
Although these problems are signiﬁcant, current efforts
to address these and other issues involved in DNA array
experiments will undoubtedly improve on current circum-
stances and will translate into many future discoveries in
cell biology. The adaptation of DNA arrays to other highly
parallel, experimental approaches such as ChIP-chip,
RNA binding and comparative genomic DNA hybridiz-
ation has enabled other areas of cell biology to beneﬁt from
the same comprehensive advantages. The further deve-
lopment of these techniques and other parallel approaches
to cell biology (e.g. see [36,37]), as well as the emergence
of data standards [3] and computational and visualization
methods, will continue to transform the process of experi-
mentation from the study of a single gene in a single
process to a whole-genome approach.
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